Eurofins Scientific SE

Eurofins Scientific SE

ESF0 · XETRA · Healthcare / Diagnostics & Research

87.72EUR-0.28 (-0.32%)

Price History

Full chart

Market Stats

Previous Close88.00
Open88.06
Day Range87.64 – 88.06
52-Week Range55.15 – 79.12
Volume1.02K
Market Cap12.84B
P/E (TTM)26.06
Forward P/E15.41
EPS2.88
Dividend Yield0.96%
Beta0.85
50-Day Avg72.38
200-Day Avg67.11

About

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEODr. Gilles G. Martin Ph.D.
  • Employees65.00K
  • Headquarters23 Val Fleuri, Luxembourg, Luxembourg, 1526, Germany
  • Websitehttps://www.eurofins.com

Leadership

  • Dr. Gilles G. Martin Ph.D.Chairman of the Board & CEO · b. 1963
  • Ms. Valerie HanoteExecutive Director · b. 1966
  • Mr. Laurent LebrasGroup Administration & CFO
  • Mr. Gonzalo MeleGroup Chief Information Officer
  • Mr. Andrew SwiftHead of Investor Relations
  • Mr. David W. BryantSenior VP of Strategic Business Development North America
  • Mr. Gabriel JuliaSenior VP of Clinical Diagnostics Europe
  • Dr. Timothy S. OostdykExecutive VP of BioPharma, Genomics & Agrosciences Services North America
  • Mr. Joachim ReicheltSenior Vice President of Food & Feed Testing Europe
  • Ms. Yvoine RemySenior Vice President of Environment Testing Europe

Financials

Income Statement

Currency: EUR2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue6.72B6.71B6.51B6.95B7.30B
Growth (%)--0.08%-2.94%+6.70%+4.96%
Cost of Revenue2.15B2.23B2.15B2.24B2.33B
Gross Profit4.57B4.49B4.36B4.71B4.97B
Gross Margin68.00%66.82%66.98%67.79%68.12%
Operating Expense3.29B3.70B3.82B3.99B4.15B
Operating Income1.28B783.20M546.80M726.20M818.30M
Operating Margin18.98%11.67%8.39%10.45%11.22%
EBITDA-1.49B1.22B1.40B1.53B
EBITDA Margin-22.27%18.68%20.09%21.03%
Net Income782.60M610.20M310.20M406.40M474.80M
Net Income Margin11.65%9.09%4.76%5.85%6.51%
Interest Expense95.00M105.60M129.40M150.80M157.10M
Interest Expense % of Total Revenue1.41%1.57%1.99%2.17%2.15%

Balance Sheet

Currency: EUR2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets9.33B10.08B10.89B10.89B10.99B
Total Liabilities4.66B5.23B5.75B5.50B6.41B
Total Equity4.65B4.78B5.08B5.34B4.54B
Cash515.30M486.60M1.22B613.90M791.20M
Net Debt1.70B2.31B2.13B2.39B3.20B

Cash Flow

Currency: EUR2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow1.51B1.14B1.02B1.32B1.40B
Capital Expenditure506.40M660.20M550.10M528.40M834.80M
Free Cash Flow1.00B476.10M467.80M790.50M564.10M
Dividends Paid130.40M192.10M191.90M95.60M107.70M
FCF to OCF66.49%41.90%45.96%59.94%40.32%
Dividend Paid to FCF12.98%40.35%41.02%12.09%19.09%

Earnings

Report DateJan 28, 2027
EPS Estimate-
EPS Actual-
Surprise-
TimingPre-market

Key Statistics & Ratios

Market Cap12.84B
Enterprise Value16.89B
Trailing P/E26.06
Forward P/E15.41
PEG Ratio0.92
Price / Sales1.74
Price / Book2.82
EPS2.88
Book Value20.85
Revenue (TTM)7.39B
Gross Profit (TTM)1.71B
EBITDA1.54B
Profit Margin7.17%
Operating Margin16.17%
Return on Equity11.33%
Return on Assets5.99%
Shares Outstanding171.11M
Shares Float110.07M
Beta0.85
Dividend Yield0.96%
Dividend Rate0.72
Payout Ratio25.00%

Dividends

20261×
0.72Apr 28, 2026
20251×
0.60Apr 28, 2025
20241×
0.50Jul 3, 2024
20231×
1.00Jul 4, 2023
20221×
1.00Jul 5, 2022
20121×
0.80Apr 4, 2012
20111×
0.20Jun 14, 2011
20102×
0.10Sep 27, 20100.10Jul 8, 2010
20091×
0.10Jun 29, 2009
20081×
0.10Jul 21, 2008